Insider · CIK 0001966673
Catharine de Lacy
Files at CLIR (ClearSign Technologies Corp). First filing -, latest -.
In brief
Catharine de Lacy files SEC Form 4 as director at CLIR (ClearSign Technologies Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Catharine de Lacy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +32,175 | $0.00 | $0 | 218,957 | Jul 3, 2025 |
| Apr 1, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +24,857 | $0.00 | $0 | 186,782 | Apr 3, 2025 |
| Jan 2, 2025 | CLIR ClearSign Technologies Corp | AGrant or award Restricted Stock Unitsderivative | +13,848 | $0.00 | $0 | 161,925 | Jan 6, 2025 |
Questions about Catharine de Lacy
Answered from the filings on this page, as of the latest one.
Is Catharine de Lacy buying or selling?
Catharine de Lacy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Catharine de Lacy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Catharine de Lacy has 0.
Where does Catharine de Lacy file Form 4?
Catharine de Lacy has filed Form 4 at CLIR (ClearSign Technologies Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.